As of 2025-09-18, the Fair Value of Nuvation Bio Inc (NUVB) is -2.96 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.26 USD, the upside of Nuvation Bio Inc is -190.66%.
With the market price of 3.26 USD and our fair value calculation, Nuvation Bio Inc (NUVB) is not a good investment. Investing in NUVB stocks now will result in a potential loss of 190.66%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -41.66 | -86.85 | -104.20 | -75.80 | -567.94 | -175.29 |
| YoY growth | -24.17% | -108.47% | -19.98% | 27.25% | -649.24% | -154.92% |
| Market Cap (mil) | 1,119.06 |
| P/E | |
| Forward P/E |
| EPS | -0.59 |
| Avg earnings growth rate | -154.92% |
| TTM earnings | -202.90 |